AGA clinical practice update: De-prescribing PPIs reduces costs, risks for adverse events

The AGA has issued a clinical practice update on de-prescribing proton pump inhibitors, according to an article in Gastroenterology.“Although PPIs are the treatment of choice for the management of acid-mediated upper gastrointestinal conditions, these agents are being used increasingly for less clear indications and for indeterminate durations,” Laura E. Targownik, MD, MSHS, a gastroenterologist at Mount Sinai Hospital and associate professor of gastroenterology and hepatology at the University of Toronto, and colleagues wrote. “As PPI use has become more common, theRead More